Obamacare Will Bring Drug Industry $35 Billion In Profits
Today 10:29 EDT
Despite expiring patents on blockbuster drugs and a wave of new regulation from the Affordable Care Act that will cost drug makers, the pharmaceutical industry will reap between “$10 billion and $35... Read More
from Forbes Real Time
There is no place like home for Victor King McElheny, a visiting scholar at MIT's School of Humanities, Arts and Sciences, and former director of the M.I.T Science Writing Program. At 70 years of age,... Read More
from Forbes Real Time
category
Pharmaceuticals
,
Medical Devices & Supplies
from Trefis
Medical Device Stocks: Buy, Sell and Watch
May 22, 2013
Gabelli Starts Abbott Labs (ABT) at Buy
May 21, 2013
- XIENCE Xpedition™ 48 Leverages Proven Design and Clinical Outcomes of the XIENCE Family of Drug Eluting Stents Read More
from PR Newswire
from Business Journals
The market continues to fear the end of the Fed’s quantitative easing as we started today’s session in negative territory. Though stocks bounced off the morning lows and spent some time in positive... Read More
from Dividend Daily
Analyst Moves: ABT, ACN, EFX, JCP
May 20, 2013
Goldman Sachs (GS) upgraded shares of Abbott Labratories (ABT) from neutral to buy citing growth of margin expansion. Additionally Goldman upgraded Accenture (ACN) shares to buy placing a $90 target... Read More
category
Stocks
from Market News Video
DailyFinance.com : U.S. equity markets opened lower this morning but soon rose above the break-even line where it stayed until noon when share prices began to dip. That was quite a shift from Asian... Read More
from DailyFinance.com
category
Pharmaceuticals
,
Medical Devices & Supplies
from Trefis
Stock Upgrades: Priceline Is Going Places
May 20, 2013
StreetInsider.com Pre-Open Movers 5/20: (AQ) (WBSN) (SCTY) Higher; (XNPT) (KMX) (SNV) Lower (more...)
May 20, 2013
Goldman Sachs analysts see Abbott Laboratories (ABT) as a fast growing company with the potential to expand its margins. As such, the analysts upgraded the pharmaceutical company on Monday. The... Read More
from Dividend Daily
Goldman Sachs Upgrades Abbott Labs (ABT) to Buy
May 20, 2013
Jim Cramer's Down and Out Turnaround Play
May 17, 2013
Cramer has been looking at long-term losers to see if any show potential. He's found something. Get all the details now. Read More
from CNBC.com News
Cramer: Break-Up Could Boost This Stock 19%
May 17, 2013
Cramer's convinced the best way to for this health care company to maximize shareholder value is to break up. "It's a tried and true formula," insisted the Mad Money host. Read More
category
Investing
,
Health Care/Health Care Equipment and Services/Health Care Equipment and Supplies/Health Care Equipm
,
Biotechnology
, and 10 more.
from CNBC.com News
As expected, MedTech mergers and acquisitions (M&A) are heating up in 2013. Finally, the... Visit StockBlogHub to view complete post. Read More
from Stock Blog Hub
from Business Journals
from Business Journals
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here